Insmed (INSM) Research & Development (2010 - 2026)
Insmed (INSM) reported Research & Development of $210.03 million for Q2 2026, up 18.5% from $177.19 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Insmed's Research & Development came in at $860.85 million, up 30.4% year-over-year; for FY2025, it was $771.09 million, up 28.9% from FY2024.
- Research & Development has increased for six consecutive years, with a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
- By year, Research & Development came in at $598.37 million in FY2024 (+4.8%), $571.01 million in FY2023 (+43.6%), $397.52 million in FY2022 (+45.7%) and $272.74 million in FY2021 (+50.6%).
- Five-year quarterly Research & Development spans a low of $70.35 million in Q3 2021 and a high of $254.91 million in Q4 2025.
- Year over year, Research & Development has now increased in each of the last eight quarters, with growth averaging 29.7% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q2 2023 (growth of 122.5%); the low point was Q2 2024 (a decline of 25.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $209.49 million (Q1 2026), $254.91 million (Q4 2025) and $186.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Insmed | 25.69 Bn | 20.19 Bn | 358.27 Mn | 210.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 210.03 Mn |
| Mar 31, 2026 | 209.49 Mn |
| Dec 31, 2025 | 254.91 Mn |
| Sep 30, 2025 | 186.42 Mn |
| Jun 30, 2025 | 177.19 Mn |
| Mar 31, 2025 | 152.58 Mn |
| Dec 31, 2024 | 179.73 Mn |
| Sep 30, 2024 | 150.81 Mn |
| Jun 30, 2024 | 146.75 Mn |
| Mar 31, 2024 | 121.08 Mn |
| Dec 31, 2023 | 137.03 Mn |
| Sep 30, 2023 | 109.15 Mn |
| Jun 30, 2023 | 196.97 Mn |
| Mar 31, 2023 | 127.87 Mn |
| Dec 31, 2022 | 124.76 Mn |
| Sep 30, 2022 | 99.87 Mn |
| Jun 30, 2022 | 88.53 Mn |
| Mar 31, 2022 | 84.36 Mn |
| Dec 31, 2021 | 76.35 Mn |
| Sep 30, 2021 | 70.35 Mn |
API Access
Insmed Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();